{
  "created_at": "Sat Mar 05 18:33:39 +0000 2022",
  "id_str": "1499912642403655683",
  "full_text": "U.S. drug regulators approved a new customized, cell-based treatment for blood cancer from Johnson &amp; Johnson that is the first such therapy in the U.S. to be developed initially in China https://t.co/sJTmbUumgM",
  "display_text_range": [
    0,
    214
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/sJTmbUumgM",
        "expanded_url": "https://on.wsj.com/3IFb53E",
        "display_url": "on.wsj.com/3IFb53E",
        "indices": [
          191,
          214
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 35,
  "favorite_count": 81,
  "possibly_sensitive": false,
  "original_created_at": "Sat Mar 05 01:00:15 +0000 2022"
}